Single base instability is promoted in vulvar lichen sclerosus

Journal of Investigative Dermatology

Volumn 127, Issue 11, 2007, Pages 2563-2576

  Tapp, Ronald A ^a   Feng, Jingtao ^a   Jones, J Wesley ^a   Carlson, J Andrew ^b   Wilson, Vincent L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FEMALE GENITAL SYSTEM; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR SUPPRESSOR GENE; VULVA DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENOMIC INSTABILITY; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; POINT MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; VULVAR LICHEN SCLEROSUS; VULVAR NEOPLASMS;

EID: 35348889604     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700889     Document Type: Article

References (91)

1. Argyris TS (1985) Regeneration and the mechanism of epidermal tumor promotion. Crit Rev Toxicol 14:211-58
2. Asplund A, Guo Z, Hu X, Wassberg C, Ponten F (2001) Mosaic pattern of maternal and paternal keratinocyte clones in normal human epidermis revealed by analysis of X-chromosome inactivation. J Invest Dermatol 117:128-31
3. Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F (2005) Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat Res 571:65-79
4. Backvall H, Stromberg S, Gustafsson A, Asplund A, Sivertsson A, Lundeberg J et al. (2004a) Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma. Exp Dermatol 13:643-50
5. Backvall H, Wolf O, Hermelin H, Weitzberg E, Ponten F (2004b) The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma. Br J Dermatol 150:259-66
6. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-16
7. Berg RJ, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, Van Kreijl CF et al. (1996) Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 93:274-8
8. Bielas JH, Loeb LA (2005) Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen 45:206-13
9. Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C (1995) Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 4:383-8
10. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-57
11. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63:1727-30
12. Branum ME, Reardon JT, Sancar A (2001) DNA repair excision nuclease attacks undamaged DNA. A potential source of spontaneous mutations. J Biol Chem 276:25421-6
13. Brash DE, Ponten J (1998) Skin Precancer. Cancer Surv 32:69-113
14. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-8
15. Cairns J (2002) Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci USA 99:10567-70
16. Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, Giannotti B (1995) Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 4:491-5
17. Carli P, De Magnis A, Mannone F, Botti E, Taddei G, Cattaneo A (2003) Vulvar carcinoma associated with lichen sclerosus. Experience at the Florence, Italy, Vulvar Clinic. J Reprod Med 48:313-8
18. Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P et al. (1998) Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case-control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 29:932-48
19. Carlson JA, Amin S, Malfetano J, Tien AT, Selkin B, Hou J et al. (2001a) Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Appl Immunohistochem Mol Morphol 9:150-63
20. Carlson JA, Grabowski R, Chichester P, Paunovich E, Malfetano J (2000) Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous - implications for pathogenesis. Am J Dermatopathol 22:7-16
21. Carlson JA, Scott D, Wharton J, Sell S (2001b) Incidental histopathologic patterns: possible evidence of 'field cancerization' surrounding skin tumors. Am J Dermatopathol 23:494-6
22. Cha RS, Thilly WG, Zarbl H (1994) N-nitroso-N-methylurea- induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc Natl Acad Sci USA 91:3749-53
23. Coller HA, Khrapko K, Torres A, Frampton MW, Utell MJ, Thilly WG (1998) Mutational spectra of a 100-base pair mitochondrial DNA target sequence in bronchial epithelial cells: a comparison of smoking and nonsmoking twins. Cancer Res 58:1268-77
24. Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430-2
25. Diaz-Llera S, Podlutsky A, Osterholm AM, Hou SM, Lambert B (2000) Hydrogen peroxide induced mutations at the HPRT locus in primary human T-lymphocytes. Mutat Res 469:51-61
26. Ellis CA, Clark G (2000) The importance of being K-Ras. Cell Signal 12:425-34
27. Finette BA, Sullivan LM, O'Neill JP, Nicklas JA, Vacek PM, Albertini RJ (1994) Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat Res 308:223-31
28. Fuchs J, Zollner TM, Kaufmann R, Podda M (2001) Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 30:337-53
29. Furukawa H, Yamamoto Y, Minakawa H, Sugihara T (2002) Squamous cell carcinoma in chronic lymphedema: case report and review of the literature. Dermatol Surg 28:951-3
30. Goodman JE, Hofseth LJ, Hussain SP, Harris CC (2004) Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 44:3-9
31. Grady WM, Markowitz SD (2002) Genetic and epigenetic alterations in colon cancer. Annu Rev Genomic Hum Genet 3:101-28
32. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-78
33. Grist SA, McCarron M, Kutlaca A, Turner DR, Morley AA (1992) In vivo human somatic mutation: frequency and spectrum with age. Mutat Res 266:189-96
34. Guinee DG Jr, Travis WD, Trivers GE, De Benedetti VM, Cawley H, Welsh JA et al. (1995) Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis 16:993-1002
35. Halliday GM (2005) Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res 571:107-20
36. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
37. Hu W, Feng Z, Tang MS (2003) Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms. Biochemistry 42:10012-23
38. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP et al. (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 60:3333-7
39. Hussain SP, Harris CC (1998) Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58:4023-37
40. Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3:276-85
41. Jensen UB, Lowell S, Watt FM (1999) The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development (Cambridge, England) 126:2409-18
42. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA et al. (1996) Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 93:14025-9
43. Kamiya H (2003) Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: survey and summary. Nucleic Acids Res 31:517-31
44. Kino K, Sugiyama H (2005) UVR-induced G-C to C-G transversions from oxidative DNA damage. Mutat Res 571:33-42
45. Knauf JA, Ouyang B, Knudsen ES, Fukasawa K, Babcock G, Fagin JA (2006) Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J Biol Chem 281:3800-9
46. Krawczak M, Smith-Sorensen B, Schmidtke J, Kakkar VV, Cooper DN, Hovig E (1995) Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection. Hum Mutat 5:48-57
47. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643-9
48. Ling G, Persson A, Berne B, Uhlen M, Lundeberg J, Ponten F (2001) Persistent p53 mutations in single cells from normal human skin. Am J Pathol 159:1247-53
49. Magewu AN, Jones PA (1994) Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol 14:4225-32
50. Martin GM, Ogburn CE, Colgin LM, Gown AM, Edland SD, Monnat RJ Jr (1996) Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet 5:215-21
51. Morley AA, Turner DR (1999) The contribution of exogenous and endogenous mutagens to in vivo mutations. Mutat Res 428:11-5
52. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK et al. (1994) UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 91:360-4
53. Neeley WL, Delaney JC, Henderson PT, Essigmann JM (2004) In vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitroimidazole. J Biol Chem 279:43568-73
54. Nishigori C, Hattori Y, Toyokuni S (2004) Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 6:561-70
55. Ouhtit A, Ueda M, Nakazawa H, Ichihashi M, Dumaz N, Sarasin A et al. (1997) Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients. Cancer Epidemiol Biomarkers Prev 6:433-8
56. Parkinson EK (1992) Epidermal keratinocyte stem cells: their maintenance and regulation. Semin Cell Biol 3:435-44
57. Ponten F, Berne B, Ren ZP, Nister M, Ponten J (1995) Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 105:402-6
58. Potten CS, Booth C (2002) Keratinocyte stem cells: a commentary. J Invest Dermatol 119:888-99
59. Regauer S, Reich O, Beham-Schmid C (2002) Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am J Pathol 160:1035-45
60. Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH et al. (2000) Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N′-nitro-N-nitrosoguanidine and promoted by mezerein. Mol Carcinogen 27:298-307
61. Ren Z, Ponten F, Nister M, Ponten J (1997a) Reconstruction of the two-dimensional distribution of p53 positive patches in sunexposed skin morphologically normal skin. Inter J Oncol 11:111-15
62. Ren ZP, Ahmadian A, Ponten F, Nister M, Berg C, Lundeberg J et al. (1997b) Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol 150:1791-803
63. Ren ZP, Ponten F, Nister M, Ponten J (1996) Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis. Int J Cancer 69:174-9
64. Robinson CG, Pipas JM (1998) SV40 large tumor antigen (T antigen): database of mutants. Nucleic Acids Res 26:295-6
65. Rohwedder A, Philips B, Malfetano J, Kredentser D, Carlson JA (2002) Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol 24:230-40
66. Rolfe KJ, MacLean AB, Crow JC, Benjamin E, Reid WM, Perrett CW (2003) TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 89:2249-53
67. Rossman TG, Goncharova EI (1998) Spontaneous mutagenesis in mammalian cells is caused mainly by oxidative events and can be blocked by antioxidants and metallothionein. Mutat Res 402:103-10
68. Ruocco V, Schwartz RA, Ruocco E (2002) Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 47:124-7
69. Sander CS, Ali I, Dean D, Thiele JJ, Wojnarowska F (2004) Oxidative stress is implicated in the pathogenesis of lichen sclerosus. Br J Dermatol 151:627-35
70. Seril DN, Liao J, Yang GY, Yang CS (2003) Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24:353-62
71. Shacter E, Weitzman SA (2002) Chronic inflammation and cancer. Oncology (Williston Park) 16:217-26, 229; discussion 230-2
72. Shen JC, Rideout WM III, Jones PA (1994) The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res 22:972-6
73. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-74
74. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-8
75. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB (1995) Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 131:796-800
76. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS et al. (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21:577-81
77. Stenzel A, Semczuk A, Rozynskal K, Jakowicki J, Wojcierowski J (2001) "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Pathol Res Pract 197:597-603
78. Sudo H, Li-Sucholeiki XC, Marcelino LA, Gruhl AN, Zarbl H, Willey JC et al. (2006) Distributions of five common point mutants in the human tracheal-bronchial epithelium. Mutat Res 596:113-27
79. Tabata H, Nagano T, Ray AJ, Flanagan N, Birch-MacHin MA, Rees JL (1999) Low frequency of genetic change in p53 immunopositive clones in human epidermis. J Invest Dermatol 113:972-6
80. Tate JE, Mutter GL, Prasad CJ, Berkowitz R, Goodman H, Crum CP (1994) Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Gynecol Oncol 53:78-83
81. Thilly WG (2003) Have environmental mutagens caused oncomutations in people? Nat Genet 34:255-9
82. Tomita-Mitchell A, Ling LL, Glover CL, Goodluck-Griffith J, Thilly WG (2003) The mutational spectrum of the HPRT gene from human T cells in vivo shares a significant concordant set of hot spots with MNNG-treated human cells. Cancer Res 63:5793-8
83. Tornaletti S, Pfeifer GP (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 10:1493-9
84. Vanin K, Scurry J, Thorne H, Yuen K, Ramsay RG (2002) Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J Invest Dermatol 119:1027-33
85. Wilson VL (2001) Detecting rare mutations associated with cancer risk. Am J Pharmacogenomics 1:283-93
86. Wilson VL, Tatford BC, Yin X, Rajki SC, Walsh MM, LaRock P (1999a) Species-specific detection of hydrocarbon-utilizing bacteria. J Microbiol Methods 39:59-78
87. Wilson VL, Wei Q, Wade KR, Chisa M, Bailey D, Kanstrup CM et al. (1999b) Needle-in-a-haystack detection and identification of base substitution mutations in human tissues. Mutat Res 406:79-100
88. Wilson VL, Yin X, Thompson B, Wade KR, Watkins JP, Wei Q et al. (2000) Oncogenic base substitution mutations in circulating leukocytes of normal individuals. Cancer Res 60:1830-4
89. Zhang W, Remenyik E, Zelterman D, Brash DE, Wikonkal NM (2001) Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci USA 98:13948-53
90. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A et al. (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20:189-93
91. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773-6